You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 醫思健康(2138.HK)高開6.16% 擬先舊後新配股淨籌2.488億港元
格隆匯 07-09 09:27
格隆匯7月9日丨醫思健康(2138.HK)高開6.16%,報15.86港元,暫成交4億港元,最新市值176億港元。醫思健康今日早間發公吿稱,於7月8日交易時段後,公司透過海通國際證券以先舊後新方式向鄭志剛及AspexMasterFund配售17,213,793股份,配股價為每股14.5港元。配售股份相當於認購事項完成後經擴大已發行股份總數約2.48%。配售價為每股股份14.5港元,較股份於該協議日期在聯交所所報的收市價每股14.94港元折讓約2.95%。假設所有配售股份獲悉數配售予買方及認購股份獲悉數認購,所得款項淨額估計約為2.488億港元。公司擬將配售事項及認購事項所得款項淨額悉數用於擴大集團於中國香港及中國大灣區的診所網絡、併購及集團的一般企業用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account